G Hoeffken

Summary

Affiliation: Technical University
Country: Germany

Publications

  1. ncbi request reprint The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia
    G Hoeffken
    University Clinic Carl Gustav Carus Medical Clinic Pneumology, Dresden, Germany
    Respir Med 95:553-64. 2001
  2. ncbi request reprint Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors
    Gert Höffken
    Department for Pulmonology, Universitatsklinikum Carl Gustav Carus, Technische Universitat Dresden, Fetscherstr 74, 01309 Dresden, Germany
    Med Microbiol Immunol 191:169-73. 2002
  3. ncbi request reprint Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens
    G Hoeffken
    Universitätsklinikum Carl Gustav Carus Technische Universität, Fetscherstrasse 74, 01307 Dresden, Germany
    Eur J Clin Microbiol Infect Dis 23:772-5. 2004

Collaborators

Detail Information

Publications3

  1. ncbi request reprint The efficacy and safety of two oral moxifloxacin regimens compared to oral clarithromycin in the treatment of community-acquired pneumonia
    G Hoeffken
    University Clinic Carl Gustav Carus Medical Clinic Pneumology, Dresden, Germany
    Respir Med 95:553-64. 2001
    ..Moxifloxacin, given once daily, is free of many drug-drug interactions and requires no dosage adjustments in most renal hepatic deficient patients...
  2. ncbi request reprint Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors
    Gert Höffken
    Department for Pulmonology, Universitatsklinikum Carl Gustav Carus, Technische Universitat Dresden, Fetscherstr 74, 01309 Dresden, Germany
    Med Microbiol Immunol 191:169-73. 2002
    ..g., patients with advanced age, underlying chronic medical conditions or presenting with severe influenza-related symptoms...
  3. ncbi request reprint Efficacy and safety of sequential moxifloxacin for treatment of community-acquired pneumonia associated with atypical pathogens
    G Hoeffken
    Universitätsklinikum Carl Gustav Carus Technische Universität, Fetscherstrasse 74, 01307 Dresden, Germany
    Eur J Clin Microbiol Infect Dis 23:772-5. 2004
    ..The results indicate IV/PO moxifloxacin (400 mg q.i.d.) is an effective monotherapy for patients with CAP due to atypical pathogens...